Ernexa Therapeutics (ERNAW) Preferred Dividend Payments (2018 - 2025)

Ernexa Therapeutics has reported Preferred Dividend Payments for 7 years, with the latest figure at $8000.0 in Q4 2025.

• For the quarter ending Q4 2025, Preferred Dividend Payments changed 0.0% year-over-year to $8000.0; the trailing twelve-month figure through Dec 2025 stood at $24000.0 (changed 0.0% YoY), and the FY2025 full-year result was $16000.0, changed 0.0% from the prior year.
• Preferred Dividend Payments for Q4 2025 stood at $8000.0, roughly flat from $8000.0 in the prior quarter.
• The five-year high for Preferred Dividend Payments was $8000.0 in Q2 2021, with the low at $8000.0 in Q2 2021.
• Historically, Preferred Dividend Payments has averaged $8000.0 across 5 years, with a median of $8000.0 in 2021.
• The largest YoY upside for Preferred Dividend Payments was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
• Ernexa Therapeutics' Preferred Dividend Payments stood at $8000.0 in 2021, then changed by 0.0% to $8000.0 in 2022, then changed by 0.0% to $8000.0 in 2023, then changed by 0.0% to $8000.0 in 2024, then changed by 0.0% to $8000.0 in 2025.
• The last three Preferred Dividend Payments figures came in at $8000.0 (Q4 2025), $8000.0 (Q2 2025), and $8000.0 (Q4 2024), per Business Quant data.